| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 01/12/2011 | EP2271660A2 Stabilized liquid enzyme compositions |
| 01/12/2011 | EP2271659A1 Compounds for treating pain |
| 01/12/2011 | EP2121922B1 Biologically active molecules, particularly based on pna and sirna, method for the cell-specific activation thereof, and application kit to be administered |
| 01/12/2011 | EP1797110B1 Antibacterial amide macrocycles iv |
| 01/12/2011 | EP1730167B1 Macrocyclic peptides active against the hepatitis c virus |
| 01/12/2011 | EP1163263B1 Dalda analogs and their use |
| 01/12/2011 | CN1894273B Peptide inhibiting angiotensin converting enzyme |
| 01/12/2011 | CN1826098B Production of small particles |
| 01/12/2011 | CN101945886A Topical compositions and methods utilizing peptides containing lipid-modified cysteine-containing peptides |
| 01/12/2011 | CN101941977A Antitumoral analogs of lamellarins |
| 01/12/2011 | CN101941946A Disubstituted benzene uracil peptide nucleic acid monomer and intermediate as well preparation methods and applications thereof |
| 01/11/2011 | US7868157 low non-specific binding, photostable, ease of chemical modification to permit tuning of absorption and emission wavelengths and resistance to the formation of dimers; 1-(5-carboxy-pentyl)-2-[5-(1-ethyl-3,3-dimethyl-5-phosphono-1,3-dihydro-indol-2-ylidene)-penta-1,3-dienyl]-3,3-dimethyl-3H-indolium |
| 01/11/2011 | US7868134 Immunogenic peptides derived from sclerostin |
| 01/11/2011 | US7868133 For diagnosis, treatment, and prevention of apoptosis associated disorders using animal models; for drug screening; chimeras; genetic engineering, cancer |
| 01/11/2011 | CA2429781C Linkable sialyl lewis x analogs |
| 01/11/2011 | CA2156360C Adhesion receptor antagonists |
| 01/06/2011 | WO2011002332A1 Synthetic peptides having anti-stress activity |
| 01/06/2011 | WO2010113035A3 Peptide-based beta turn mimetics |
| 01/06/2011 | US20110003752 New Blood Coagulation Factor Inhibitors |
| 01/06/2011 | US20110003751 Novel Immunoregulatory Peptides, Compositions and Uses Thereof |
| 01/06/2011 | US20110002969 Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors |
| 01/06/2011 | CA2766162A1 Smac mimetic |
| 01/05/2011 | EP2270040A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 01/05/2011 | EP2270026A2 Compounds for proteasome enzyme inhibition |
| 01/05/2011 | EP2270019A1 New synthetic route for the preparation of alpha-amino boronic esters |
| 01/05/2011 | EP2270005A1 Prodrug of an ice inhibitor |
| 01/05/2011 | EP2270004A1 Caspase inhibitors and uses thereof |
| 01/05/2011 | EP2269980A1 Creatine amides, a method for the production thereof and an agent exhibiting a neuroprotective action |
| 01/05/2011 | EP2268619A1 Fluorinated macrocyclic compounds as hepatitis c virus inhibitors |
| 01/05/2011 | EP2268607A2 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid |
| 01/05/2011 | EP2016950B1 Pharmaceutical composition comprising an exendin-4 peptide |
| 01/05/2011 | EP1912999B1 Macrocyclic inhibitors of hepatitis c virus |
| 01/05/2011 | EP1745064B1 Compounds for proteasome enzyme inhibition |
| 01/05/2011 | CN101939329A Amino acid pairing-based self assembling peptides and methods |
| 01/05/2011 | CN101939313A 3,8-diaminotetrahydroquinoline derivative |
| 01/05/2011 | CN101935337A Preparation method of histone deacetylase inhibitor FK228 |
| 01/05/2011 | CN101935336A Method for preparing water-soluble taxane medicament and application thereof |
| 01/04/2011 | US7863417 which activate synthesis reactions in skin matrix by specifically stimulating growth factor TGF beta 1 responsible for anabolism of macromolecules therein; antiwrinkling |
| 01/04/2011 | US7863411 Comprises polypeptide, protein and/or peptide which recognize and bind to prion envelope protein for use as diagnostic tool in detecting spongiform encephalopathies; screening and removing prions from fluid products; preventing viral infection |
| 01/04/2011 | US7863284 such as N-{N-{4-[N-(2-methoxymethyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclo-penta[g]quinazolin-6-yl)-N-(prop-2-ynyl)amino]benzoyl}-L- gamma -glutamyl}-D-glutamic acid, used for aiding regression and palliation of ovarian cancer; antiproliferative agents |
| 01/04/2011 | US7862816 Identifying ephrin inhibitors for use in treatment and prevention of cell proliferative and angiogenesis disorders; antitumor agents |
| 01/04/2011 | CA2573307C Use of platelet aggregation inhibitors |
| 01/04/2011 | CA2500190C Linker compound, ligand, and producing method thereof |
| 01/04/2011 | CA2488363C O-substituted hydroxyaryl derivatives |
| 01/04/2011 | CA2468039C Novel peptide having angiotensin converting enzyme inhibitory effect |
| 12/30/2010 | US20100331535 Conjugates and compositions for cellular delivery |
| 12/30/2010 | US20100331489 Branched water-soluble polymers and their conjugates |
| 12/30/2010 | US20100331355 Substituted Quinolines for the Treatment of Cancer |
| 12/30/2010 | US20100331260 Stabilized bitamin c derivatives having a peptide molecule, preparation method thereof, and composition containing the same |
| 12/30/2010 | US20100331243 Organic compounds and their uses |
| 12/30/2010 | US20100330700 Substrate for assaying beta-glucan and/or endotoxin and assay method |
| 12/30/2010 | US20100330109 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 12/30/2010 | US20100330075 Monoclonal human tumor-specific antibody |
| 12/29/2010 | EP2267020A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 12/29/2010 | EP2267019A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 12/29/2010 | EP2267018A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 12/29/2010 | EP2267017A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 12/29/2010 | EP2267016A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 12/29/2010 | EP2267015A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 12/29/2010 | EP2266999A2 Compounds for proteasome enzym inhibition |
| 12/29/2010 | EP2266986A1 Cytotoxins, Prodrugs, Linkers and Stabilizers useful therefor |
| 12/29/2010 | EP2104535B1 Compounds and compositions as channel activating protease inhibitors |
| 12/29/2010 | EP2015726B1 Cosmetic composition for stimulating the synthesis of proteins of the basement membrane |
| 12/29/2010 | CN1930183B Biologically active peptides comprising phenylalanyl-glutamate (FE) and phenylalanyl-glutamyl-glutamate (FEE) |
| 12/29/2010 | CN1856504B Anti-infarction molecules |
| 12/29/2010 | CN101928458A Preparation method of multifunctional nanometer composite particle constructed by modified polymine |
| 12/29/2010 | CN101928329A Tripeptide boric acid (ester) compound and preparation method and application thereof |
| 12/29/2010 | CN101928328A RGD peptide-epimedium flavone combination, preparation method and application thereof |
| 12/29/2010 | CN101928327A Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes |
| 12/29/2010 | CN101928326A Substitution five-heterocyclic alkyl aminoacyl compound and application thereof |
| 12/28/2010 | USRE42013 Macrocyclic modulators of the ghrelin receptor |
| 12/28/2010 | US7858776 (2,3-cis)-3-amino-2-phenyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one; for treatment of neurological disorders related to amyloid beta protein production such as Alzheimer's disease; inhibit gamma secretase and thereby inhibit the production of amyloid beta protein |
| 12/28/2010 | US7858741 Stabilization of the collagen triple helix by O-methylation of hydroxyproline residues |
| 12/28/2010 | US7858737 Heterogeneous foldamers containing α, β, and/or γ-amino acids |
| 12/28/2010 | US7858679 Polymeric compositions and related methods of use |
| 12/28/2010 | US7858625 Conjugates and compositions for cellular delivery |
| 12/23/2010 | WO2010147666A1 Compounds useful as carbonic anhydrase modulators and uses thereof |
| 12/23/2010 | WO2010147547A1 Novel peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation |
| 12/23/2010 | WO2010147158A1 Gel enclosing a compound by means of low-molecular weight gelling agent |
| 12/23/2010 | WO2010145376A1 Tripeptide boronic acid or boronic ester, preparative method and use thereof |
| 12/23/2010 | US20100324265 Process for the preparation glatiramer acetate (copolymer-1) |
| 12/23/2010 | US20100323973 Conjugates containing hydrophilic spacer linkers |
| 12/23/2010 | US20100323969 Compounds Binding to P-Selectin |
| 12/23/2010 | US20100323953 Macrocyclic hepatitis c protease inhibitors |
| 12/23/2010 | US20100322948 Bone morphogenetic protein (BMP)-binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and use of same |
| 12/22/2010 | EP2264498A1 Optical coupling device with optical waveguide coupled to optical device |
| 12/22/2010 | EP2264047A1 High purity lipopeptides, lipopeptide micelles and processes for preparing same |
| 12/22/2010 | EP2089020B1 Macrocyclic peptides as hepatitis c virus inhibitors |
| 12/22/2010 | EP2086980B1 Macrocyclic peptides as hepatitis c virus inhibitors |
| 12/22/2010 | EP1737819B1 Amino acid and peptide conjugates of arylalkylic acids for cosmetic use |
| 12/22/2010 | CN101921313A Polypeptide for curing or preventing cancer or derivative product and application thereof |
| 12/22/2010 | CN101921309A L-cystyl-2-L-aspartic tripeptide and derivatives, preparation method and application thereof |
| 12/22/2010 | CN101921308A Compound with anti-HCV activity and application thereof |
| 12/22/2010 | CN101920196A Hydrogenation catalyst for synthesizing neotame and preparation method thereof |
| 12/22/2010 | CN101338305B Process for extracting superoxide dismutase and reduction glutathion from animal blood |
| 12/21/2010 | US7854934 For treatment of cancer, preferably for prevention of recurrence of cancer, and for inducing antibodies in subject by administering glycopeptides |
| 12/21/2010 | CA2464130C Mch antagonists for the treatment of obesity |
| 12/21/2010 | CA2460956C Tetrapeptide derivative crystals |
| 12/21/2010 | CA2411981C Urokinase inhibitors |
| 12/21/2010 | CA2220753C Novel peptides and compositions which modulate apoptosis |